Table 4 Stratification According to Menopause: Comparison of Pathological Results Between HPV16 + and HPV16/18/45 + Groups, n (%)
From: Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
Premenopausal group | Postmenopausal group | ||||
|---|---|---|---|---|---|
HPV16+, n(%) | HPV18/45+, n(%) | HPV16+, n(%) | HPV18/45+, n(%) | ||
Pathological results of cervical biopsy | LSIL- | 174(53.3) | 51(85.0) | 47(46.5) | 14(70.0) |
HSIL+ | 153(46.8) | 9(15.0) | 54(53.5) | 6(30.0) | |
Ca | 17(5.2) | 1(1.7) | 24(23.8) | 2(10.0) | |
327 | 60 | 101 | 20 | ||
χ2 value | 21.109 | 4.637 | |||
P value | < 0.001 | = 0.2 | |||